Increasing evidence in scientific journals declares that stem cell can be used in human medicine for therapeutic purposes. We reviewed the lated literature on clinical trials conducted with stem cells. The main information was offered by http://www.ClinicalTrials.gov. These clinical trials cover almost all human diseases, from hematologic diseases to non-hematologic diseases including Interventional trials and observational trials. In conclusion, at present, the clinical trials with stem cells have been extending to almost all human diseases. Optimal medicinal effect reported in some non-hematologic diseases is pushing the advance of stem cells therapy.
INTRODUCTION
Stem cells are generally defined as cells exhibiting two properties: a capacity for self-renewal and potency for multilineage differentiation [1] . Since the first case on bone marrow transplantation, studies on stem cells therapy have been extending into almost all kinds of human diseases for repairing defected tissue and function. http://www.ClinicalTrials.gov offers up-to-date information for a wide range of diseases and conditions. The studies listed in this database are conducted in 181 countries. We analyzed the information obtained from http://www.ClinicalTrials.gov with "stem cells" as the searching words. As of June 11, 2012 , there were 4061 clinical trials including ongoing, completed and terminated clinical trials worldwide. Base on this database we presented some information on stem cells therapy in the future.
As showed in Figure 1 , it is obvious that stem cells are increasingly used in the clinical trials of treating non-hematologic diseases, which makes up the major part.
In addition, the promising outcome has been generated on the study of hematologic diseases. It indicates the further clinical applications. Also, there are some stem cell-related trials in the searching results, which are referred as "others" in the Figure 1 , this part is considered as the safety and efficacy studies. It mainly includes the harvesting, purifying and identifying process of stem cells, the treatment of complication especially graftversus-host disease after transplantation and so on. They compose a large part of the clinical trials of stem cells as well. [6] has completed a clinical trial and got prospective results [7] . The allogenic stem cell transplantation can cause immunologic rejection, so people develop transplantation with autologous stem cells. Fred Hutchinson Cancer Research Center [8] set the clinical studies about autologous peripheral blood stem cell transplant for the treatment of acute myelogenous leukemia, which was approved on November 1, 1999. Emory University [9] , University of Bologna. Autologous Transplantation for Multiple Myeloma [10] , Fudan University [11] and an increasing number of people sponsored clinical trials with autologous stem cells.
CLINICAL TRIALS ON HEMATOLOGIC DISEASES

CLINICAL TRIALS ON NON-HEMATOLOGIC DISEASES
As the results about stem cells have improved a lot, peonple consider them as a newly-developed cure for some incurable non-hematologic diseases. Referring to the right chart in Figure 1 , stem cells therapy about nonhematologic diseases mainly focus on the management of cancers and heart diseases. However, disease like systemic lupus erythematosus lacking effective cure is also the goal of stem cells therapy. The range of diseases is extending and the number is increasing.
Heart and Vascular Diseases
Heart failure has sustained its place as the leading cause of death in the United States over the past two decades and is characterized by the progression of electrical and mechanical dysfunction [12] . There are plenty of clinical trials for the pursue of curing untreatable heart diseases, such as acute myocardial infarction (AMI). National Heart Institute, Mexico [13] , Meshalkin Research Institute of Pathology of Circulation [14] , Barts & The London NHS Trust [15] , University of Zurich [16] investigated clinical trials with autologous stem cell injection to improve the heart function after acute myocardial infarction. Kyoto Prefectural University of Medicine [17] developed a clinical trial to study the treatment for congestive heart failure, ischemic cardiomyopathy, ventricular dysfunction with autologous cardiac-derived stem cells.
Metabolic Disorders
Metabolic disorders especially diabetes have generated great attention due to the living quality improving. Without effective treatment changing the situation, the studies about stem cells offer a new sight for the treatment. Shanghai Jiao Tong University School of Medicine [18] sponsored a clinical trial on the application of stem cells in treating type1 diabetes. The findings reported were with 67% of patients remaining noninsulin dependent at the 12-month follow-up and the remarkable increase of C-peptide production suggesting improved β cell function [19] . Also, clinical trials on other metabolic disorders emerged. Boston Medical Center [20] 
Immune Diseases
The first nonmyeloablative allogenic hematologic stem cell transplantation (AHST) was performed in a single patient with severe refractory systemic lupus erythematosus in Genoa in 1996, with positive outcome [25] . Consequently, clinical trials on systemic lupus erythematosus showed up first on July 5, 2000 [26] . Then, National Cancer Institute (NCI) [27] , Charite University, Berlin, Germany [28] , Richard Burt, MD [29] , National Heart, Lung, and Blood Institute (NHLBI) [30] 
Cancers
In 2007, cancer caused about 13% of all human deaths worldwide (7.9 million). Rates are rising as more people live to an old age and as mass lifestyle changes occur in the developing world [33] . Cancer cells own the ability of unregulated growth, which leads to the difficulty of treatment. Cancer is usually treated with chemotherapy, radiation therapy and surgery, but the large scale of killing cells makes the situation worse. Stem cell transplantation provides an approach for cell replacement and tissue repairing during the treating process. H. Lee Moffitt Cancer Center and Research Institute [34] , Robert H. Lurie Cancer Center [35] , Northwestern University [36] have been studying chemotherapy plus stem cell transplantation in treating breast cancer in different trials.
CONCLUSIONS
As shown above, stem cells therapy has been widely tried in clinical trials. For the reason that bone marrow or hematologic stem cell transplant has been used in clinic for the treatment of leukemia [37], the main focus of stem cell clinical trials has been extended to the application in non-hematologic diseases from hematologic diseases. In addition, the high attack rate and low recovery ratio of non-hematologic diseases urge researchers to develop stem cells therapy as a fresh relief and cure way. The properties of stem cells provide a brilliant view in treating the refractory non-hematologic diseases, e.g. the potency for neuron differentiation makes stem cells relieve the symptoms of Parkinson's syndrome. Besides, both kinds of clinical trials are still ongoing (Table 1) although the ratio of non-hematologic diseases in clinical trials has surpassed that of hematologic diseases.
With the data of stem cell clinical trials, it has a great chance that stem cells therapy can gain a bright future in non-hematologic diseases. However, it is particularly important to investigate the safety and efficacy of stem 
